Screen fetal genetic risks early and plan with your clinician

NIFTY Mono is a non-invasive prenatal screening test using a maternal blood sample to assess the chance of selected monogenic conditions. A screening result is not a diagnosis.

Order Now

Talk to Our Team

Why consider monogenic screening?

Genetic conditions are not always visible before birth

A monogenic condition can occur without a known family history

Some genetic variants arise spontaneously.

Some conditions may not be visible on ultrasound

Some features may become apparent only as a child develops.

Prenatal screening panels differ

Not all prenatal screening tests assess monogenic conditions.

Who may consider NIFTY Mono?

NIFTY Mono screening may be considered from 10 weeks of pregnancy. Discuss individual circumstances and suitability with your clinician.

Family and pregnancy history

Pregnancy conceived through IVF

Family history of dominant monogenic conditions

Questions about fetal genetic screening

Ultrasound findings to discuss with a clinician:

Bone or skeletal structure
Heart
Fetal nervous system

NIFTY Mono screening information

Non-invasive sample

The test uses a maternal blood sample and is non-invasive.

Screening limitations

Performance varies by condition and variant. Screening is not a diagnosis; discuss results and follow-up with your clinician.

Panel coverage

BGI describes its panel as screening for 202 dominant monogenic conditions associated with 155 target genes. Check the current panel list with your clinician; coverage may change.

NIFTY Mono screening panel

Manufacturer-reported current panel: 202 dominant monogenic conditions. Panel coverage and category counts may change; confirm the current list with your clinician.

97

Multisystem syndromes

51

Skeletal system syndromes

36

Neurological and muscular syndromes

18

Intellectual disability and immunodeficiency syndromes